| Sample | Title | Value | Rank |
|---|
| GSM303966 | SLE-7 #4 @12wks, asymptomatic (-2077090517) | 32.8677 | 45 |
| GSM303972 | SLE-7 #3 @12wks, asymptomatic (-2077090523) | 30.2489 | 42 |
| GSM303986 | SLE-7 #2 @12wks, asymptomatic (-2077090529) | 37.7257 | 48 |
| GSM303991 | SLE-7 #1 @12wks, asymptomatic (-2077090535) | 37.8435 | 47 |
| GSM303961 | SLE-7 #1 @36wks, asymptomatic on treatment with sirolimus (-2101366109) | 32.4618 | 40 |
| GSM303979 | SLE-7 #3 @36wks, asymptomatic on treatment with sirolimus (-2101365196) | 29.6121 | 37 |
| GSM303985 | SLE-7 #2 @36wks, asymptomatic on treatment with sirolimus (-2101365652) | 27.7234 | 39 |
| GSM303971 | SLE-7 #2 @36wks, diseased/symptomatic (-2101366115) | 37.5999 | 46 |
| GSM303973 | SLE-7 #1 @36wks, diseased/symptomatic (-2101366147) | 31.3132 | 40 |
| GSM303980 | SLE-7 #3 @36wks, diseased/symptomatic (-2102085829) | 43.2959 | 46 |
| GSM303962 | SLE-7 #3 @42wks, asymptomatic on treatment with sirolimus (-2101365164) | 32.8862 | 41 |
| GSM303978 | SLE-7 #2 @42wks, asymptomatic on treatment with sirolimus (-2102085846) | 33.6948 | 41 |
| GSM303982 | SLE-7 #1 @42wks, asymptomatic on treatment with sirolimus (-2101365170) | 31.1728 | 37 |
| GSM303965 | SLE-7 #2 @42wks, diseased/symptomatic (-2102085823) | 25.8857 | 34 |
| GSM303968 | SLE-7 #1 @42wks, diseased/symptomatic (-2101365185) | 35.4813 | 45 |
| GSM303981 | SLE-7 #3 @42wks, diseased/symptomatic (-2101365176) | 34.0419 | 43 |